Medical condition
Inflammation
Inflammation is a medical condition tracked by NovaPharmaNews across 12 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- besilesomab (SCINTIMUN) Various (V09)
- lamivudine (3TC) Antiinfectives for systemic use (J05)
- entecavir (ENTAC) Antiinfectives for systemic use (J05)
- dupilumab (DUPIXENT) Dermatologicals (D11)
- dexamethasone (DEXMETHSONE) Systemic hormonal preparations (H02)
- upadacitinib (RINVOQ) Antineoplastic and immunomodulating agents (L04)
- telbivudine (SEBIVO) Antiinfectives for systemic use (J05)
- secukinumab (COSENTYX) Antineoplastic and immunomodulating agents (L04)
- peginterferon alfa-2a (PEGASYS) Antineoplastic and immunomodulating agents (L03)
- nepafenac (NEVANAC) Sensory organs (S01)
- ixekizumab (TALTZ) Antineoplastic and immunomodulating agents (L04)
- golimumab (SIMPONI) Antineoplastic and immunomodulating agents (L04)